AAOpt 2023: Success of getting contact lens dropouts back in daily disposables

News
Article

At the 2023 AAOpt annual meeting, data was presented on the frequency of success of patients struggling with contact lens drop out getting back into daily disposable lenses.

Andrew D. Pucker, OD, PhD, FAAO, FSLS, FBCLA, shared highlights from his poster, "Frequency of Successfully Bringing Contact Lens Dropouts Back into a Modern Daily Disposable Contact Lens at 6-Months," which he presented during the 2023 American Academy of Optometry in New Orleans.

Editor's note: This transcript has been edited for clarity.

Andrew D. Pucker, OD, PhD, FAAO, FSLS, FBCLA:

My name is Andrew Pucker, I'm the Senior Director of Clinical and Medical Sciences at Lexitas Pharma Services. I'm excited to be presenting my poster at Academy this year, which is on understanding how well patients can do with Dailies Total 1 for the first 6 months after being a contact lens drop out.

So, we enrolled subjects who were struggling with contact lenses, they really couldn't wear them anymore. What we wanted to do is see if we could bring them back into wearing lenses. We put everyone, all 60 subjects, into Dailies Total 1. We saw them in-person for a fitting, we [follow-up] in that one month in-person. Then, the focus of my poster has been the 6 month survey data.

What we found was that the vast majority of patients, over 80% of patients, were still wearing Dailies Total 1 at 6 months. [It's] amazing that they were people who are pretty much giving up on contact lenses, and now they're happy, healthy contact lens wearers again. With that, the same patients are happy to recommend these contact lenses to a friend, and they can wear them pretty much all day.

I think one of the big clinical takeaways we need to give to our patients is that if you are a contact lens wearer and struggling, there are options for you. So if you [are] not quite happy, make sure it's known to your doctor. The doctor should be actively asking these questions as well. If you find out that they're struggling, you should just offer them an alternative option, and [a] potentially good one is Dailies Total 1.

What's next for this research? Well, we only have data on Dailies Total 1. What we could potentially do is look at other modern contact lenses. This work was based on work from [Dr] Young [in] around 2002. In that study, they allowed patients to try any contact lens and they found that roughly 75% of patients could resume contact lenses. But, the data we have here is just on one lens and we could expand that to any modern lens and see if other lenses can perform as well.

Recent Videos
In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
© 2024 MJH Life Sciences

All rights reserved.